NASDAQ:MBAI MBody AI (MBAI) Stock Price, News & Analysis $2.70 -0.40 (-12.90%) As of 01:54 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsNews and TrendsSEC Filings About MBody AI Stock (NASDAQ:MBAI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MBody AI alerts:Sign Up Key Stats Today's Range$2.62▼$3.0850-Day Range$3.01▼$9.8752-Week Range$2.62▼$27.44Volume20,584 shsAverage Volume123,843 shsMarket Capitalization$3.73 millionP/E RatioN/ADividend YieldN/APrice Target$10.00Consensus RatingHold Company Overview MBody AI, Inc. (NASDAQ:MBAI) is a technology company focused on applying artificial intelligence to health, wellness and body-composition management. Its business centers on developing digital tools intended to help users better understand and manage aspects of their fitness, nutrition and overall well-being. The company’s products and services are designed to use data-driven insights and personalized recommendations to support individual health and wellness goals. Publicly available information about MBody AI’s specific product portfolio, operating geographies and leadership team is limited. MBody AI is an emerging company, and additional details about its commercial operations and corporate history may become available through future regulatory filings and company disclosures. AI Generated. May Contain Errors. Read More MBody AI Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks59th Percentile Overall ScoreMBAI MarketRank™: 2.948734758095 of 5 starsMBody AI scored higher than 59% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingMBody AI has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialMBody AI has a consensus price target of $10.00, representing about 228.4% upside from its current price of $3.05.Amount of Analyst CoverageMBody AI has only been the subject of 3 research reports in the past 90 days.Read more about MBody AI's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of MBody AI is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MBody AI is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMBody AI has a P/B Ratio of 0.92. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.42% of the float of MBody AI has been sold short.Short Interest Ratio / Days to CoverMBody AI has a short interest ratio ("days to cover") of 0.95, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MBody AI has recently decreased by 8.06%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMBody AI does not currently pay a dividend.Dividend GrowthMBody AI does not have a long track record of dividend growth. News and Social Media2.4 / 5News SentimentN/A News SentimentMBody AI has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for MBody AI this week, compared to 2 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, MBody AI insiders have not sold or bought any company stock.Percentage Held by Insiders0.48% of the stock of MBody AI is held by insiders.Percentage Held by Institutions1.07% of the stock of MBody AI is held by institutions.Read more about MBody AI's insider trading history. Receive MBAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MBody AI and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MBAI Stock News HeadlinesMBody AI Adds 2 Patents Pending for Its Enterprise AI Workforce PlatformOctober 8, 2026 | globenewswire.comMBody AI Brings Physical AI Robotics Platform to ThinkEquity and Maxim InvestorsOctober 7, 2026 | globenewswire.comA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the eye-popping yields are fueling a boom among everyday investors. Three years ago, barely a dozen of these funds existed - today there are more than 100, holding over $140 billion. These funds trade on the NYSE and NASDAQ and are built to generate monthly income. Some investors are targeting $5,000 a month with roughly one-tenth of the nest egg Wall Street says you need.October 16 at 1:00 AM | Investors Alley (Ad)MBody AI Presents AI Robot Workforce Platform at Lytham Fall 2026 ConferenceSeptember 28, 2026 | globenewswire.comMBody AI Completes Name Change Following Merger and $10 Million OfferingSeptember 16, 2026 | globenewswire.comMBody AI to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 10, 2026 | globenewswire.comMBody AI Advances AI Robotics Rollout at Mohegan SunSeptember 9, 2026 | globenewswire.comMBody AI Orchestrator Named Finalist for AI Deployment of the YearSeptember 2, 2026 | globenewswire.comSee More Headlines MBAI Stock Analysis - Frequently Asked Questions How have MBAI shares performed this year? MBody AI's stock was trading at $12.0050 at the beginning of the year. Since then, MBAI stock has decreased by 74.6% and is now trading at $3.0450. When did MBody AI's stock split? MBody AI shares reverse split on the morning of Wednesday, August 12th 2026.A 1-7 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, August 11th 2026. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. How do I buy shares of MBody AI? Shares of MBAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/16/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 3 weeks, MBAI's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:MBAI CIK1610590 Webwww.mbody.ai Phone972-4-8303400Fax972-4821-1267Employees85Year FoundedN/APrice Target and Rating Average Price Target for MBody AI$10.00 High Price Target$10.00 Low Price Target$10.00 Potential Upside/Downside+272.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$3.49 per share Price / Cash Flow0.77 Book Value$3.30 per share Price / Book0.81Miscellaneous Outstanding Shares1,380,000Free Float1,368,000Market Cap$3.71 million OptionableN/A Beta0.66 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:MBAI) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersYFT Could Be Building the Future of Drug Discovery!MindWalk Holdings (NASDAQ: HYFT) is applying AI to drug discovery, and its customer base already includes 19 o...Trading Wire | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | Sponsored$29.97... or free todayBill Poulos's report, The Trading For Income System, normally sells for $29.97. Today, it's free through this ...Profits Run | SponsoredThe oil check Munger called his best dealCharlie Munger's $1,000 oil investment in 1962 later paid about $70,000 a year, totaling roughly $1 million ov...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBody AI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBody AI With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
